The addition of doxazosin to the treatment regimen of patients with hypertension not adequately controlled by by β-blockers-Reference-Cited by-同舟云学术

The addition of doxazosin to the treatment regimen of patients with hypertension not adequately controlled by by β-blockers

Published:1991-01 Issue:1 Volume:121 Page:311-316
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Englert Rudolf Georg,Barlage Uwe

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Antihypertensive agents which inhibit sympathetic activity: potentially adverse effects of combination treatment;Drayer;Am Heart J,1982

2. Vasodilators in hypertension—a review with special emphasis on the combined use of vasodilators and beta-adrenoceptor blockers;Eggertsen;Int J Clin Pharmacol Ther Toxicol,1985

3. Prazosin update;Stanaszek;Drugs,1983

4. Prazosin in long-term therapy of moderate/severe hypertension;Salvadeo;Curr Ther Res,1981

5. Prazosin in therapy of arterial hypertension: double-blind comparisons and combinations;de Divitiis;Drugs Exp Clin Res,1981

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redefining beta-blocker use in hypertension: selecting the right beta-blocker and the right patient;Journal of the American Society of Hypertension;2017-01

2. Drug Therapy for Resistant Hypertension: Simplifying the Approach;The Journal of Clinical Hypertension;2010-11-08

3. In vivo administration of doxazosin in rats highly decreases serum circulating levels of testosterone through a mechanism involving the testicular renin–angiotensin system;International Journal of Andrology;2008-06

4. Doxazosin in the current treatment of hypertension;Expert Opinion on Pharmacotherapy;2008-03

5. Combined α/β-Blockade: An Underused Approach to the Treatment of Resistant Hypertension;The Journal of Clinical Hypertension;2007-09